Mast cell activation and autism

Biochim Biophys Acta
January 2012
https://www.sciencedirect.com/science/article/pii/S0925443910002954

Morphine reduced perceived anger from neutral and implicit emotional expressions

Psychoneuroendocrinology
May 2018
https://pubmed.ncbi.nlm.nih.gov/29550675/

Low-dose naltrexone for disease prevention and quality of life

Med Hypotheses
March 2009
https://pubmed.ncbi.nlm.nih.gov/19041189/

Low-Dose Naltrexone in Diseases' Treatment: Global Review

Etiological Pathways Toward Autism and Diversities of Treatments: From Unimodal to Multidimensional Approaches

Neuropsychoanalysis
February 2016
http://www.tandfonline.com/doi/abs/10.1080/15294145.2016.1156388

Naltrexone in young autistic children: replication study and learning measures

J Am Acad Child Adolesc Psychiatry
November 1997
https://www.ncbi.nlm.nih.gov/pubmed/?term=19393386

Objective: This study expanded upon previous work on naltrexone efficacy and safety in young autistic children and assessed performance on learning measures.

Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form
     in French

Encephale
April 2009
https://www.ncbi.nlm.nih.gov/pubmed/?term=19393386

Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone

Ann Ist Super Sanita
1996
https://www.ncbi.nlm.nih.gov/pubmed/?term=9028057

Novel and emerging treatments for autism spectrum disorders: a systematic review

Ann Clin Psychiatry
Oct-Dec 2009
https://www.ncbi.nlm.nih.gov/pubmed/?term=19917212

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study

Biol Psychiatry
June 1996
https://www.ncbi.nlm.nih.gov/pubmed/?term=8780837